Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Related

• 

  Complications or Are They: Why We Can NEVER Get Enough ReST

  Jeffrey S. Heier, MD

  Peter K. Kaiser, MD FASRS

  Geoffrey G. Emerson, MD, PhD, FASRS

  J. Michael Jumper, MD, FASRS

  Ehab N. ELRAYES, MD, PhD ,FASRS

  Daniel Simhaee, MD

  ASSAF DOTAN, MD

  Paul Hahn, MD, PhD, FASRS

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2018

• 

  The Cilioretinal Artery is Protective Against Choroidal Neovascularization in Age-Related Macular Degeneration

  Glenn C. Yiu, MD, PhD

  Annual Meeting Talks

  2018

• 

  Retinoschisis in Coats Disease: Clinical Picture, Therapeutic Considerations, Management Outcomes and Histopathological Correlation

  Audina M. Berrocal, MD FASRS

  Annual Meeting Talks

  2018